ArriVent Biopharma, Inc.
ArriVent Biopharma, Inc. (AVBP) is a publicly traded company in the Unknown sector. Across all available filings, 9 corporate insiders have executed 30 transactions totaling $34.0M, demonstrating a bullish sentiment with $34.0M in net insider flow. The most recent transaction on Feb 2, 2026 involved a transaction of 130,000 shares valued at $0.
AVBP Insider Activity Summary
Who Is Buying AVBP Stock?
No significant insider buying has been recorded for AVBP in the recent period.
Who Is Selling AVBP Stock?
No significant insider selling has been recorded for AVBP in the recent period.
Is ArriVent Biopharma, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for AVBP is bullish with an Insider Alignment Score of 100/100 and a net flow of $34.0M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
AVBP Frequently Asked Questions
Understanding AVBP Insider Activity
Insider trading at ArriVent Biopharma, Inc. (AVBP) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 9 insiders are actively trading AVBP stock, having executed 30 transactions in the past 90 days. The most active insider is Advisors, Ltd. Hhlr (Executive), who has made 3 transactions totaling $10.0M.
Related Tools
Track ArriVent Biopharma, Inc. Insider Activity
Get notified when executives and directors at AVBP file new Form 4 transactions